High-flow nasal cannula oxygen therapy for breast surgery patients under gerenal anesthesia reserved spontaneous breathing: a randomized controlled clinical trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029881

Enrollment

Unknown

Registered

2020-02-16

Start date

2020-02-11

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast disease

Interventions

Group A:High-flow nasal cannula oxygen therapy

Group B:Laryngeal mask

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Elective breast surgery patients under gerenal anesthesia; 2. Aged 18 to 75 years, both male or female; 3. Compliance with ASA classification at I-II level; 4. Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Preoperative visits to patients with probable difficult airway; 2. Severe cardiopulmonary and renal dysfunction, severe psychiatric or psychological disorder; 3. Severe coagulation disorders; 4. Patients during pregnancy and lactation; 5. Patients with narcotic contraindication.

Design outcomes

Primary

Measure	Time frame
Intraoperative dosage of sedatives and opioid;the incidence of hypoxia;Postoperative sore throat score;Postoperative Nausea and vomiting score;Patient satisfaction score;	—

Secondary

Measure	Time frame
Recovery time;	—

Countries

China

Contacts

Public ContactFang Xiangming

The First Affiliated Hospital of Zhejiang University Medical College

xiangming_fang@163.com+86 18958023168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026